Identity
- Trade Name
- PHOSPHORUS FDA UDI
- Generic Name
- Inorganic phosphate (PO43-) IVD, kit, spectrophotometry FDA UDI
- Model / Reference
- PHOS-0230 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 03661540216206 FDA UDI
- GMDN Term
- Inorganic phosphate (PO43-) IVD, kit, spectrophotometry FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Inorganic phosphate (PO43-) IVD, kit, spectrophotometry
Phosphorus by Vitalscientific — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Inorganic phosphate (PO43-) IVD, kit, spectrophotometry.
- Alinity — Abbott · Class I
- Atellica CH IP — Siemens Healthcare Diagnostics · Class I
- CAROLINA LIQUID CHEMISTRIES CORP.® PHOSPHORUS REAGENT KIT ST218 — Carolina Liquid Chemistries Corp. · Class I
- Alinity — ABBOTT IRELAND · Class I
- CAROLINA LIQUID CHEMISTRIES CORP.® PHOSPHORUS REAGENT KIT CC218 — Carolina Liquid Chemistries Corp. · Class I
- ADVIA® Chemistry IP Inorganic Phosphorus Reagents — Siemens Healthcare Diagnostics · Class I
- Phosphate (Inorganic) ver.2 — Roche Diagnostics Corp. · Class I
- ARCHITECT — Abbott Laboratories, Inc. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Vitalscientific
Sources (1)
- FDA UDI c3ea5826-a985-4671-beb9-84828535ed03 32 fields · synced May 30, 2026